BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 11771853)

  • 1. Lipophilic statins can be osteogenic by promoting osteoblastic calcification in a Cbfa1- and BMP-2-independent manner.
    Izumo N; Fujita T; Nakamuta H; Koida M
    Methods Find Exp Clin Pharmacol; 2001 Sep; 23(7):389-94. PubMed ID: 11771853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins inhibit osteoblast migration by inhibiting Rac-Akt signaling.
    Fukuyama R; Fujita T; Azuma Y; Hirano A; Nakamuta H; Koida M; Komori T
    Biochem Biophys Res Commun; 2004 Mar; 315(3):636-42. PubMed ID: 14975748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluvastatin and lovastatin but not pravastatin induce neuroglial differentiation in human mesenchymal stem cells.
    Lee OK; Ko YC; Kuo TK; Chou SH; Li HJ; Chen WM; Chen TH; Su Y
    J Cell Biochem; 2004 Nov; 93(5):917-28. PubMed ID: 15389871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Core-binding factor alpha 1 (Cbfa1) induces osteoblastic differentiation of C2C12 cells without interactions with Smad1 and Smad5.
    Nishimura R; Hata K; Harris SE; Ikeda F; Yoneda T
    Bone; 2002 Aug; 31(2):303-12. PubMed ID: 12151083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incadronate and etidronate accelerate phosphate-primed mineralization of MC4 cells via ERK1/2-Cbfa1 signaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate.
    Fujita T; Izumo N; Fukuyama R; Meguro T; Yasutomi C; Nakamuta H; Koida M
    Jpn J Pharmacol; 2001 May; 86(1):86-96. PubMed ID: 11430477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The role of mevalonate pathway in osteogenic cells].
    Ishimi Y
    Nihon Rinsho; 2004 Feb; 62 Suppl 2():779-82. PubMed ID: 15035226
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stimulation of bone formation by anti-hyperlipidemic agent statins and its mechanism of action].
    Yoneda T
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():688-95. PubMed ID: 11979970
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation.
    Lee MH; Javed A; Kim HJ; Shin HI; Gutierrez S; Choi JY; Rosen V; Stein JL; van Wijnen AJ; Stein GS; Lian JB; Ryoo HM
    J Cell Biochem; 1999 Apr; 73(1):114-25. PubMed ID: 10088730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins inhibit blastocyst formation by preventing geranylgeranylation.
    Alarcon VB; Marikawa Y
    Mol Hum Reprod; 2016 May; 22(5):350-63. PubMed ID: 26908642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptosis of rheumatoid synovial cells by statins through the blocking of protein geranylgeranylation: a potential therapeutic approach to rheumatoid arthritis.
    Nagashima T; Okazaki H; Yudoh K; Matsuno H; Minota S
    Arthritis Rheum; 2006 Feb; 54(2):579-86. PubMed ID: 16447234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.
    Maeda T; Matsunuma A; Kurahashi I; Yanagawa T; Yoshida H; Horiuchi N
    J Cell Biochem; 2004 Jun; 92(3):458-71. PubMed ID: 15156558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rho-dependent inhibition of the induction of connective tissue growth factor (CTGF) by HMG CoA reductase inhibitors (statins).
    Eberlein M; Heusinger-Ribeiro J; Goppelt-Struebe M
    Br J Pharmacol; 2001 Aug; 133(7):1172-80. PubMed ID: 11487529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures.
    Luppen CA; Smith E; Spevak L; Boskey AL; Frenkel B
    J Bone Miner Res; 2003 Jul; 18(7):1186-97. PubMed ID: 12854828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interferon-inducible p204 protein acts as a transcriptional coactivator of Cbfa1 and enhances osteoblast differentiation.
    Liu CJ; Chang E; Yu J; Carlson CS; Prazak L; Yu XP; Ding B; Lengyel P; Di Cesare PE
    J Biol Chem; 2005 Jan; 280(4):2788-96. PubMed ID: 15557274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluvastatin inhibits matrix metalloproteinase-1 expression in human vascular endothelial cells.
    Ikeda U; Shimpo M; Ohki R; Inaba H; Takahashi M; Yamamoto K; Shimada K
    Hypertension; 2000 Sep; 36(3):325-9. PubMed ID: 10988259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins augment vascular endothelial growth factor expression in osteoblastic cells via inhibition of protein prenylation.
    Maeda T; Kawane T; Horiuchi N
    Endocrinology; 2003 Feb; 144(2):681-92. PubMed ID: 12538631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy.
    Ogata Y; Takahashi M; Takeuchi K; Ueno S; Mano H; Ookawara S; Kobayashi E; Ikeda U; Shimada K
    J Cardiovasc Pharmacol; 2002 Dec; 40(6):907-15. PubMed ID: 12451324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells.
    Sugiyama M; Kodama T; Konishi K; Abe K; Asami S; Oikawa S
    Biochem Biophys Res Commun; 2000 May; 271(3):688-92. PubMed ID: 10814523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprenoids responsible for protein prenylation modulate the biological effects of statins on pancreatic cancer cells.
    Gbelcová H; Rimpelová S; Knejzlík Z; Šáchová J; Kolář M; Strnad H; Repiská V; D'Acunto WC; Ruml T; Vítek L
    Lipids Health Dis; 2017 Dec; 16(1):250. PubMed ID: 29262834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions.
    Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM
    Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.